Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.2.2
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2020 [1] 77,340,057        
Balance at the beginning at Dec. 31, 2020 $ 75,877        
Balance at the end (in shares) at Mar. 31, 2021 [1] 77,340,057        
Balance at the end at Mar. 31, 2021 $ 75,877        
Balance at the beginning (in shares) at Dec. 31, 2020 [1]   9,846,830      
Balance at the beginning at Dec. 31, 2020 (84,805) $ 1 $ 10,110 $ 0 $ (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   1,563,281      
Issuance of common stock upon net exercise of stock options 453   453    
Stock-based compensation cost 322   322    
Issuance of warrant to purchase common stock 1   1    
Net loss (13,506)       (13,506)
Balance at the end (in shares) at Mar. 31, 2021 [1]   11,410,111      
Balance at the end at Mar. 31, 2021 $ (97,535) $ 1 10,886 0 (108,422)
Balance at the beginning (in shares) at Dec. 31, 2020 [1] 77,340,057        
Balance at the beginning at Dec. 31, 2020 $ 75,877        
Balance at the end (in shares) at Jun. 30, 2021 [1] 77,340,057        
Balance at the end at Jun. 30, 2021 $ 75,877        
Balance at the beginning (in shares) at Dec. 31, 2020 [1]   9,846,830      
Balance at the beginning at Dec. 31, 2020 (84,805) $ 1 10,110 0 (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Cumulative translation adjustment 0        
Net loss (36,483)        
Balance at the end (in shares) at Jun. 30, 2021 [1]   13,360,382      
Balance at the end at Jun. 30, 2021 $ (119,226) $ 1 12,172 0 (131,399)
Balance at the beginning (in shares) at Dec. 31, 2020 [1] 77,340,057        
Balance at the beginning at Dec. 31, 2020 $ 75,877        
Balance at the beginning (in shares) at Dec. 31, 2020 [1]   9,846,830      
Balance at the beginning at Dec. 31, 2020 (84,805) $ 1 10,110 0 (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of warrant to purchase common stock 0        
Net loss (10,888)        
Balance at the end (in shares) at Dec. 31, 2021 [1]   142,745,021      
Balance at the end at Dec. 31, 2021 $ 290,274 $ 14 396,064 0 (105,804)
Balance at the beginning (in shares) at Mar. 31, 2021 [1] 77,340,057        
Balance at the beginning at Mar. 31, 2021 $ 75,877        
Balance at the end (in shares) at Jun. 30, 2021 [1] 77,340,057        
Balance at the end at Jun. 30, 2021 $ 75,877        
Balance at the beginning (in shares) at Mar. 31, 2021 [1]   11,410,111      
Balance at the beginning at Mar. 31, 2021 (97,535) $ 1 10,886 0 (108,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   1,993,936      
Issuance of common stock upon net exercise of stock options 206   206    
Stock-based compensation cost 1,080   1,080    
Cumulative translation adjustment 0        
Issuance of warrant to purchase common stock 0        
Repurchase of common stock upon settlement of related party note (in shares) [1]   (43,665)      
Net loss (22,977)       (22,977)
Balance at the end (in shares) at Jun. 30, 2021 [1]   13,360,382      
Balance at the end at Jun. 30, 2021 (119,226) $ 1 12,172 0 (131,399)
Balance at the beginning (in shares) at Dec. 31, 2021 [1]   142,745,021      
Balance at the beginning at Dec. 31, 2021 290,274 $ 14 396,064 0 (105,804)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   496,971      
Issuance of common stock upon net exercise of stock options 227   227    
Issuance of common stock upon vesting of restricted stock units (in shares) [1]   80,044      
Stock-based compensation cost 3,952   3,952    
Net loss (13,801)       (13,801)
Balance at the end (in shares) at Mar. 31, 2022 [1]   143,322,036      
Balance at the end at Mar. 31, 2022 $ 280,652 $ 14 400,243 0 (119,605)
Balance at the end (in shares) at Jun. 30, 2022 0        
Balance at the beginning (in shares) at Dec. 31, 2021 [1]   142,745,021      
Balance at the beginning at Dec. 31, 2021 $ 290,274 $ 14 396,064 0 (105,804)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 849,859        
Cumulative translation adjustment $ (10)        
Net loss (39,487)        
Balance at the end (in shares) at Jun. 30, 2022 [1]   143,829,995      
Balance at the end at Jun. 30, 2022 $ 260,206 $ 14 405,493 (10) (145,291)
Balance at the end (in shares) at Jun. 30, 2022 0        
Balance at the beginning (in shares) at Mar. 31, 2022 [1]   143,322,036      
Balance at the beginning at Mar. 31, 2022 $ 280,652 $ 14 400,243 0 (119,605)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   350,092      
Issuance of common stock upon net exercise of stock options 157   157    
Issuance of common stock upon vesting of restricted stock units (in shares) [1]   157,867      
Stock-based compensation cost 5,093   5,093    
Cumulative translation adjustment (10)     (10)  
Net loss (25,686)       (25,686)
Balance at the end (in shares) at Jun. 30, 2022 [1]   143,829,995      
Balance at the end at Jun. 30, 2022 $ 260,206 $ 14 $ 405,493 $ (10) $ (145,291)
[1] The shares of the Company’s convertible preferred stock and common stock, prior to the Merger (as defined in Note 1) have been retrospectively restated to reflect the exchange ratio of 0.378 established in the Merger as described in Note 3.